$3.46
-0.14-3.89%
Last update: Oct 15, 5:47 PM
$3.65
0.051.39%
Bicycle Therapeutics PLC
BCYCNASDAQ
Bicycle Therapeutics (BCYC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.53 | $-0.62 | $-0.97 | $-1.08 |
| Actual | $-0.72 | $-0.87 | $-0.29 | $-0.85 |
| Surprise | -35.9% | -40.3% | +70.1% | +21.3% |
| Revenue | ||||
| Estimate | $5.4M | $7.6M | $8.3M | $9.1M |
| Actual | $629000 | $887000 | $48.0M | $11.7M |
| Surprise | -88.4% | -88.4% | +478.2% | +28.6% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.43 | $-0.39 |
| Revenue | ||
| Consensus | $14.0M | $4.0M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $-0.72 | $-0.53 | -35.9 % |
| Q1 | Apr 30, 2026 | $-0.87 | $-0.62 | -40.3 % |
| Q4 | Mar 17, 2026 | $-0.29 | $-0.97 | 70.1 % |
| Q3 | Oct 30, 2025 | $-0.85 | $-1.08 | 21.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $629.00K | $5.42M | -88.4 % |
| Q1 | Apr 30, 2026 | $887.00K | $7.62M | -88.4 % |
| Q4 | Mar 17, 2026 | $47.96M | $8.29M | 478.2 % |
| Q3 | Oct 30, 2025 | $11.73M | $9.12M | 28.6 % |
